Actinium Completes Technology Transfer for Manufacturing of Its Lead Drug Candidate Iomab™-B Dec 19, 2013
Actinium Pharmaceuticals Announces Clinical Advisory Board Meeting At The 2013 ASH Conference Dec 9, 2013
Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting Dec 9, 2013
